Health Insurance will distribute monofilaments to general practitioners for screening for diabetic neuropathy. Unrecognized lesions can lead to amputation of the foot.
In 2013, another 8,000 amputations were performed on diabetics. Faced with this terrible toll, the Health Insurance has just launched a call for tenders to distribute 40,000 monofilaments to general practitioners so that they can measure the loss of foot sensitivity in their diabetic patients and make the diagnosis of diabetic neuropathy on the optionally.
Foot injury prevention sessions remain underutilized
With this market notice published on October 4 and relayed by the Medical Press Agency, the Social Security wishes to remedy the “underuse” of the prevention session for grade 2 or 3 risky foot lesions in diabetic patients, performed by chiropodists and prescribed mostly by general practitioners.
With this market notice published on October 4 and relayed by the Medical Press Agency, the Social Security wishes to remedy the “underuse” of the prevention session for grade 2 or 3 risky foot lesions in diabetic patients, performed by chiropodists and prescribed mostly by general practitioners.
According to Health Insurance, “the number of patients having had outpatient podiatry care sessions (POD) barely reaches half of its target population and the number of sessions per patient remains well below the expected number of sessions. However, the organization recalls that it reimburses on the basis of four sessions per year for grade 2 and six sessions per year for grade 3, these consultations for diabetics.
These prevention sessions are essential since the diabetic’s problem lies essentially in the fact that his sensory loss can prevent him or delay the awareness of the ailments from which he suffers.
These prevention sessions are essential since the diabetic’s problem lies essentially in the fact that his sensory loss can prevent him or delay the awareness of the ailments from which he suffers.
243,000 diabetics are affected by this screening
In the end, Cnamts wants to be able to start distributing the devices from mid-November. Candidates keen to improve the detection and prevention of sensory neuropathy in the foot have until Wednesday, October 23 to make themselves known.
The High Authority for Health (HAS) estimates the target population of this service to be around 243,000 patients. This summer, the Health Insurance launched a similar initiative to provide general practitioners with self-monitoring devices that will be loaned to their patients, as part of the prevention of high blood pressure.
.
